Available:*
Library | Item Barcode | Call Number | Material Type | Item Category 1 | Status |
---|---|---|---|---|---|
Searching... | 30000010042337 | QP144.F85 A57 2007 | Open Access Book | Book | Searching... |
Searching... | 30000010197367 | QP144.F85 A57 2007 | Open Access Book | Book | Searching... |
Searching... | 30000010197366 | QP144.F85 A57 2007 | Open Access Book | Book | Searching... |
On Order
Summary
Summary
The ability to regulate and manipulate the generation or remodeling of blood vessels is key to the successful treatment of many chronic diseases, both oncological and non-oncological. Several bioactive compounds present in human diets are now known to exert an inhibitive effect on the either the signaling or construction of new blood vessels. The identification and characterization of these anti-angiogenic molecules opens a new avenue for the research and production of functional and medicinal foods with far reaching implications for the food-based treatment of chronic degenerative disease.
Drawing from an extensive list of esteemed international contributors, Anti-Angiogenic Functional and Medicinal Foods explores the history and scope of the use of conventional foods, nutraceuticals, and health products in North America, Europe, the Middle East, Asia, India, Australia, and New Zealand. Recent advancements in proteomics, genomics, and toxicogenomics give us a far more detailed picture of the molecular basis of nutrition and systems toxicology. Explaining the role of angiogenesis in various chronic diseases, individual chapters consider endothelial cell responses, the mechanism of the angiogenic cascade, and the angiogenic function involved in tumors, cardiovascular disease, inflammatory arthritis, and obesity. A collection of chapters studies specific foods and their functional bioactive compounds such as the effects of edible berry anthocyanins, various Chinese medicinal foods, dietary flavonoids, probiotics, shark cartilage, EPA and DHA, and marine polysaccharides. The book concludes with a discussion of the challenges faced during the development and delivery of anti-angiogenic functional food products.
Presenting the current research and state of the science, Anti-Angiogenic Functional and Medicinal Foods provides researchers, scientists, clinical nutritionists, and oncologists with a valuable reference to this important and growing mode of
Author Notes
Jack N. Losso, Fereidoon Shahidi, Debasis Bagchi
Table of Contents
Part I History and Scope of Functional Foods Around the World | |
Chapter 1 Scope of Conventional and Functional Foods in the U.S.A | p. 1 |
Chapter 2 Functional Foods, Nutraceuticals and Natural Health Products in Canada | p. 33 |
Chapter 3 History and Scope of Functional Foods in Japan | p. 49 |
Chapter 4 Functional Foods in India: History and Scope | p. 69 |
Chapter 5 History and Scope of Functional Foods in China | p. 97 |
Chapter 6 History and Current Status of Functional Foods in Korea | p. 127 |
Chapter 7 Australia and New Zealand | p. 139 |
Chapter 8 Prophylactic Phenolic Antioxidants in Functional Foods of Tropical Island States of the Mascarene Archipelago (Indian Ocean) | p. 149 |
Chapter 9 Functional Foods in Mediterranean and Middle Eastern Countries: History, Scope and Dietary Habits | p. 177 |
Chapter 10 Functional Foods in the European Union | p. 213 |
Chapter 11 Functional Foods in the European Union: Main Issues and Impact on the Food Industry | p. 251 |
Chapter 12 Functional Foods Legislation In Brazil | p. 275 |
Part II The "Ohmics" Technologies and Functional Foods | |
Chapter 13 Principles of Proteomics | p. 291 |
Chapter 14 Toxicogenomics and Systems Toxicology | p. 315 |
Part III Angiogenesis and Chronic Degenerative Diseases | |
Chapter 15 Endothelial Cell Responses to Physiological and Pathophysiological Environments | p. 349 |
Chapter 16 Angiogenic Switch: Roles of Estrogenic Compounds | p. 365 |
Chapter 17 Reactive Oxygen Species and Angiogenesis | p. 389 |
Chapter 18 Angiogenesis in Inflammatory Arthritis | p. 403 |
Chapter 19 Angiogenesis and Cardiovascular Diseases | p. 441 |
Chapter 20 Angiogenesis and Anti-Angiogenesis in Brain Tumors | p. 453 |
Chapter 21 Diabetes and Angiogenesis | p. 469 |
Chapter 22 Obesity and Angiogenesis | p. 499 |
Part IV Angiogenesis, Functional, and Medicinal Foods | |
Chapter 23 Screening Functional Foods as Inhibitors of Angiogenesis Biomarkers | p. 507 |
Chapter 24 Role of Edible Berry Anthocyanins in Angiogenesis | p. 527 |
Chapter 25 Redox Regulation of Angiogenesis: Anti-Angiogenic Properties of Edible Berries and Its Significance in a Clinical Setting | p. 549 |
Chapter 26 A Novel Nutrient Mixture Containing Ascorbic Acid, Lysine, Proline, and Green Tea Extract Inhibits Critical Parameters in Angiogenesis | p. 561 |
Chapter 27 Angiogenesis and Chinese Medicinal Foods | p. 581 |
Chapter 28 Disposition and Metabolism of Dietary Flavonoids | p. 593 |
Chapter 29 Functional Foods: Probiotics | p. 611 |
Chapter 30 Potential Anti-Cancer Effects of Shark Cartilage | p. 625 |
Chapter 31 Physiological Effects of Eicosapentaenoic Acid (EPA) and Docosahexaenoic Acid (DHA) - A Review | p. 635 |
Chapter 32 Marine Polysaccharides and Angiogenesis: Modulation of Angiogenesis by Fucoidans | p. 651 |
Chapter 33 Development and Delivery of Anti-Angiogenic Functional Food Products: Opportunities and Challenges | p. 673 |
Index | p. 699 |